Efficacy of Bicarbonate on the Risk of Assisted Delivery in Nulliparous Women With Prolonged Labour

NCT07321379 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1520

Last updated 2026-01-12

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if oral bicarbonate can treat prolonged labour in nulliparous women with prolonged labour.

The main question it aims to answer is: Do oral bicarbonate and restrictive oxytocin use reduce assisted delivery rate (emergency cesarean and vacuum/forceps delivery) in nulliparous women with prolonged labour.

Researchers will compare bicarbonate and placebo (a look-alike substance that contains no drug) to see if bicarbonate works to treat prolonged labour.

Participants will:

* drink bicarbonate or placebo
* have cervical dilatation reassessed after 2 hours. If still slow progression, they will follow standard protocol for oxytocin augmentation
* will receive a questionnaire 1 month post partum to assess birth experience

1/3 of participants will have amniotic fluid lactate measured at inclusion and after 2 hours

Conditions

  • Prolonged Labor
  • Labor Dystocia

Interventions

DRUG

Sodium bicarbonate

4,26 gram given once.

DRUG

Placebo

Placebo given once.

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER
  • Rigshospitalet, Denmark

    collaborator OTHER
  • Aarhus University Hospital

    collaborator OTHER
  • Copenhagen Trial Unit, Center for Clinical Intervention Research

    collaborator OTHER
  • University of Liverpool

    collaborator OTHER
  • University of Amsterdam

    collaborator OTHER
  • Copenhagen University Hospital, Hvidovre

    lead OTHER

Principal Investigators

  • Nanna Maaløe, PhD · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2028-01-31
Completion
2028-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07321379 on ClinicalTrials.gov